Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Randomized trial of cardiac resynchronization shows positive results

Aug. 31, 2000

Bayer announces large cerivastatin trial in acute MI

Aug. 31, 2000

Dietary changes affect homocysteine levels and possibly the risk of heart disease

Aug. 31, 2000

LU-135252 normalizes pulmonary arterial pressure and blood pressure in two experimental models

Aug. 30, 2000

Selective dopamine agonist provides antiarrhythmic benefits in chronic heart failure

Aug. 30, 2000

Dual ETA/ETB antagonist provides hemodynamic benefits in CHF

Aug. 30, 2000

Bayer's MTP inhibitor assessed preclinically

Aug. 30, 2000

Low-dose transdermal testosterone tested in chronic stable angina

Aug. 30, 2000

Results of dosing studies on tezosentan in CHF reported

Aug. 29, 2000

Mast cell tryptase explored as a marker in stable CAD

Aug. 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...